Beck Mack & Oliver’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History

Beck Mack & Oliver’s Portfolio RGN Stock Details RGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-18,000	Closed	-$8K	–	302
2015 Q4	$8K	Hold	18,000	–	–	﹤0.01%	286
2015 Q3	$7K	Buy	+18,000	New	+$7K	﹤0.01%	318

Other funds holding RGN

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return

Beck Mack & Oliver's RGN Position: Q1 2016 in Review

Beck Mack & Oliver sold out of REGENERX BIOPHARMACEUTICALS (RGN) in Q1 2016, closing a stake of 18,000 shares — an estimated $8K sold.

Beck Mack & Oliver first reported a position in RGN in Q3 2015 and held it in 2 quarters. The position peaked at $8K in Q4 2015. 1 fund tracked by Wall St. Rank holds RGN as of Q1 2016.

Beck Mack & Oliver reported no remaining REGENERX BIOPHARMACEUTICALS position as of Q1 2016 after selling out during the quarter.
Beck Mack & Oliver sold 18,000 REGENERX BIOPHARMACEUTICALS shares in Q1 2016, an estimated $8K.
Beck Mack & Oliver first reported a position in REGENERX BIOPHARMACEUTICALS in Q3 2015 and held it in 2 quarters.
Beck Mack & Oliver's REGENERX BIOPHARMACEUTICALS position peaked at $8K in Q4 2015.
1 fund tracked by Wall St. Rank held REGENERX BIOPHARMACEUTICALS as of Q1 2016.

Based on Beck Mack & Oliver's 13F filing for Q1 2016, filed 27 Apr 2016.